Molecular Partners AG
MOLNNASDAQHealthcare● Active
$3.95
$-0.15(-3.66%)
Market Cap$148168932
P/E Ratio—
52W High$5.36
52W Low$3.41
Molecular Partners AG (MOLN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MOLN · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.45
Est. -$0.38 · -18.4%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS
MOLN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 24, 2026 | -$0.43 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.38 | -$0.45 | -18.4% | — | — | — |
| ▼ Q1 FY2026 | Mar 12, 2026 | -$0.40 | -$0.41 | -2.5% | — | — | — |
| ▲ Q4 FY2025 | Oct 30, 2025 | -$0.46 | -$0.41 | +10.9% | — | — | — |
| ▼ Q3 FY2025 | Aug 25, 2025 | -$0.53 | -$0.67 | -26.4% | — | — | — |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.42 | -$0.50 | -18.6% | — | — | — |
| ▲ Q1 FY2025 | Mar 6, 2025 | -$0.44 | -$0.34 | +22.7% | — | — | — |
| ▲ Q4 FY2024 | Oct 31, 2024 | -$0.63 | -$0.57 | +9.5% | $0.00B | $0.00B | +1.3% |
Q3 FY2026
Aug 24, 2026
EPS Actual
—
EPS Est.
-$0.43
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$0.45
EPS Est.
-$0.38
EPS Surpr.
-18.4%
Revenue
—
Q1 FY2026
Mar 12, 2026Miss
EPS Actual
-$0.41
EPS Est.
-$0.40
EPS Surpr.
-2.5%
Revenue
—
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
-$0.41
EPS Est.
-$0.46
EPS Surpr.
+10.9%
Revenue
—
Q3 FY2025
Aug 25, 2025Miss
EPS Actual
-$0.67
EPS Est.
-$0.53
EPS Surpr.
-26.4%
Revenue
—
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.50
EPS Est.
-$0.42
EPS Surpr.
-18.6%
Revenue
—
Q1 FY2025
Mar 6, 2025Beat
EPS Actual
-$0.34
EPS Est.
-$0.44
EPS Surpr.
+22.7%
Revenue
—
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
-$0.57
EPS Est.
-$0.63
EPS Surpr.
+9.5%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.34 | $-0.34 | $-0.34 | 1 |
| Q3 FY2027 | $-0.32 | $-0.32 | $-0.32 | 1 |
| Q2 FY2027 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q1 FY2027 | $-0.39 | $-0.39 | $-0.39 | 1 |
| Q4 FY2026 | $-0.37 | $-0.37 | $-0.37 | 1 |
| Q3 FY2026 | $-0.35 | $-0.35 | $-0.35 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -18.4% | $4.13 | $4.04 | -2.18% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -2.5% | $4.86 | $4.71 | -3.09% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +10.9% | $3.75 | $3.77 | +0.53% |
| ▼ Q3 FY2025 | Aug 25, 2025 | -26.4% | $3.67 | $4.22 | +14.99% |
| ▼ Q2 FY2025 | May 15, 2025 | -18.6% | $3.91 | $3.85 | -1.53% |
| ▲ Q1 FY2025 | Mar 6, 2025 | +22.7% | $4.90 | $4.90 | +0.00% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +9.5% | $6.15 | $5.36 | -12.85% |
| ▲ Q3 FY2024 | Aug 26, 2024 | +59.5% | $6.23 | $6.19 | -0.64% |
Q2 FY2026-2.18%
Report Date
May 12, 2026
EPS Beat/Miss
-18.4%
Price Before
$4.13
Price After
$4.04
Q1 FY2026-3.09%
Report Date
Mar 12, 2026
EPS Beat/Miss
-2.5%
Price Before
$4.86
Price After
$4.71
Q4 FY2025+0.53%
Report Date
Oct 30, 2025
EPS Beat/Miss
+10.9%
Price Before
$3.75
Price After
$3.77
Q3 FY2025+14.99%
Report Date
Aug 25, 2025
EPS Beat/Miss
-26.4%
Price Before
$3.67
Price After
$4.22
Q2 FY2025-1.53%
Report Date
May 15, 2025
EPS Beat/Miss
-18.6%
Price Before
$3.91
Price After
$3.85
Q1 FY2025+0.00%
Report Date
Mar 6, 2025
EPS Beat/Miss
+22.7%
Price Before
$4.90
Price After
$4.90
Q4 FY2024-12.85%
Report Date
Oct 31, 2024
EPS Beat/Miss
+9.5%
Price Before
$6.15
Price After
$5.36
Q3 FY2024-0.64%
Report Date
Aug 26, 2024
EPS Beat/Miss
+59.5%
Price Before
$6.23
Price After
$6.19
Avg Beat Reaction-3.24%
Avg Miss Reaction+2.05%
Beat Rate4 / 8 quarters
Largest Move+14.99% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MOLN ends December
Molecular Partners AG (MOLN) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.45 — missing the analyst consensus of $-0.38 by -18.4%. The next MOLN earnings date is expected around September 1, 2026.
Each quarter, investors track MOLN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MOLN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MOLN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MOLN earnings · 5 questionsMolecular Partners AG's next earnings report is expected around September 1, 2026. MOLN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MOLN historically reports after market close (AMC).
MOLN earnings datewhen is MOLN earningsMOLN next earnings datewhen does MOLN report earningsMOLN earnings calendar
▸ Source: FMP · Molecular Partners AG SEC filings · US GAAP · Molecular Partners AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026